Thursday , January 28 2021

Novartis with new approval



The US Food and Drug Administration granted Novartis an extended approval for its drug Promacta. This medicine helps in severe aplastic anemia. This is a disease of the hematopoietic system characterized by a decrease in all blood cells and a low hematopoietic cell count in the bone marrow. At the end of the week, the FDA has now given its extended approval, …Read the full article …

Source link